Steven R. Schutt received his B.S. in Chemistry in 1952 from Roosevelt College in Chicago. He is a 1953 graduate of Keeler Polygraph Institute in Chicago.
For the last thirty-one years Mr. Schutt has been conducting extensive and in-depth research in the field of biochemistry and has received five U.S. patents for his unique bio-chemical creations.
At the same time, Mr. Schutt worked as a forensic chemist with law enforcement organizations all over the world. Stepping away from that role in the late 90s, he returned to his original field of chemistry, obtaining several more patents in the pharmaceutical and cosmaceutical fields.
In 2003 Mr. Schutt formed Triamino Corporation in association with his partner, John Everding, who has served as his advisor since 1998. In 2008 Mssrs. Schutt and Everding formed Luminec Corp. and its associated companies.
The Science behind the Luminec Corporation
Over 40 years of diligent research by Mr. Schutt produced a benzoate (a new molecular moiety) that releases Free Amino Ions when placed in an aqueous solution. Free Amino Ions in an aqueous solution promote protein stability, which in turn restores cellular function. The new molecule, argino-glycino-parabenzoate (named Triamino™) is a reaction product and unique molecular moiety, which because of weak hydrogen bonding, causes a release of free amino ions when in aqueous solution. These free amino ions combine with the nucleic acids (within unstable protein nuclei) to achieve the most stable form, and by a process of biosynthesis, causes those formerly unstable proteins to realign. The resulting cellular redifferentiation causes the formerly dysfunctional cells to return to their original preprogrammed function because of already implanted DNA coding. This phenomenon has many positive physiological effects on dysfunctional human and animal cells such as reversing the funcelosa within those dysfunctional cells, thus restoring them to their normal function.
In addition, Mr. Schutt has produced another new molecular moiety (a fulvate) that not only releases Free Amino Ions but is one of the most effective anti-microbial, anti-viral, anti-fungal, agents known to mankind. The combining of Triamino with chemically pure Fulvic has not only augmented the Triamino molecule, but has added the benefits of the most effective and totally anti-microbial, anti-viral and anti-fungal agent known. Toxic microbes, viruses and fungi do not, and cannot, form an immunity to its action. This second new moiety has the chemical name argino-glycino-parabenzoic-fulvate (called TAFA400™). The moiety maintains all of the benefits of Triamino and adds the superb anti-microbial, anti-viral and anti-fungal effects of Fulvic acid without any toxic side effects. It also accelerates the speed of Triamino’s anti-inflammatory action.
Scientists at Imperial College of London, a science-based institution whose contributions include the discovery of penicillin, the development of holography and the foundations of fiber optics, announced on January 16, 2011 that they have identified a protein that acts as a “master switch” in certain white blood cells, determining whether they promote or inhibit inflammation. Inflammatory responses are an important defense that the body uses against infections or tissue damage.
The new study has shown that a protein called IRF5 acts as a molecular switch and seems to work by switching on genes that stimulate inflammatory responses and dampening genes that inhibit them. It can either do this by interacting with DNA directly, or by interacting with other proteins that themselves control which genes are switched on. [1]
Proteins are made up of amino acids and are reinforced by the amino acid complex in Triamino™ formula. The reason TAFA400™ is so effective and noticeably accelerates the action of the Triamino™ portion of the molecule, is that fulvate has a remarkable propensity for bonding with all proteins.
People with a poor immune system will benefit from this discovery as a boost in the protein will help in improving their immunity to diseases and infections.
There currently exists convincing, tangible medical evidence that aqueous solutions of the benzoate and the fulvate both produce remarkable results in patients.
[1] Source: Scientists Find the “Master Switch” For Key Immune Cells in Inflammatory Diseases StudyImperial College London News Release, 1800 London time, Sunday 16 January 2011